Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNSA-binding site is a specific region (region Ib) within Site I on human serum albumin (HSA), located in subdomain IIA. It is characterized by its high affinity for Dansyl-L-asparagine (DNSA). This site plays a crucial role in the transport of various drugs and endogenous substances by albumin. Ligand binding to this region is reversible, leading to potential drug-drug interactions due to competition for binding. Understanding this site is important for predicting pharmacokinetic profiles and potential adverse effects during polypharmacy.
Reversible binding of drugs and other ligands, influencing their distribution and availability.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Albumin (DNSA-binding site) (None).